ECM Weekly (5 May 2025) - CATL, Chery, Ather, Drinda, Eco-Shop, Green Tea, DN Sol, Lotte Glo, Hanwha
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
586 Views
Sichuan Biokin A/H Listing: Good Time for Listing
Sichuan Biokin is looking at A-H listing. We looked at the company's latest development, including its 2024 results and the upcoming milestones. We...
313 Views
Duality Biotherapeutics (映恩生物) Trading Update
Duality Biotherapeutics raises $194m in global offering will list on Hong Kong Stock Exchange on April 14th. We provide an update before its...
461 Views
China Healthcare Weekly (Feb.9) - Vesync Is a High-Quality Company, VBP to Cover Retail Pharmacies
Promoting VBP in retail pharmacy may harm valuation.Biotech funding gap widens, investors advised to focus on leading companies. Vesync is a good...
605 Views
Sichuan Biokin (百利天恒) H-Listing: Impressive Clinical Results so Far
We look at Sichuan Biokin's H-share listing briefly. We analyzed its key product BL-B01D1, its deal with BMS, company's team and its A-share listings.
757 Views